Sara Carter on Fentanyl and the National Drug Control Strategy

Sarah Carter, the former Director of the White House Office of National Drug Control Policy under President Trump, provides a critical update on the ongoing battle against fentanyl and its deadly analogs. Carter emphasizes the threat posed by carfentanil, a fentanyl variant that is 100 times more potent and responsible for thousands of deaths across the United States. Despite the alarming rise in overdose fatalities, Carter highlights the progress made under President Trump's administration, including a significant reduction in overdose deaths from over 112,000 to under 67,000. Carter discusses the international dimensions of the drug crisis, including efforts to curb the flow of precursor chemicals from countries like China and India, and the collaboration with countries such as Mexico to intercept drug shipments. She also warns the public about the dangers of counterfeit pills being sold online and urges parents to educate their children about the lethal risks of these substances. This interview underscores the severity of the fentanyl crisis and the steps being taken to combat it.